— Know what they know.
Not Investment Advice

BBBT OTC

Black Bird Biotech, Inc.
1W: +0.0% 1M: +0.0% 3M: +9900.0% YTD: +0.0% 1Y: +0.0% 3Y: -50.0% 5Y: -99.6%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 46 · $98405 mcap · 983M float · 0.188% daily turnover · Short 9% of daily vol

Balance Sheet Trends

Total Assets
$219K -71.8% ▼
5Y CAGR: +168.3%
Total Liabilities
$869K +735.3% ▲
5Y CAGR: -0.7%
Shareholders Equity
-$650K -197.0% ▼
Cash & Investments
$44K -91.1% ▼
5Y CAGR: +95.1%
Total Debt
$670K +1048.2% ▲
5Y CAGR: -1.2%
Net Debt
$625K +241.7% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2018FY2019FY2020FY2021FY2022
— Assets —
Cash$5K$973$53K$500K$44K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$5K$973$53K$500K$44K
Net Receivables$0$0$0$3K$2K
Inventory$0$0$40K$74K$88K
Other Current Assets$0$0$0$0$0
Total Current Assets$5K$973$106K$678K$135K
Property, Plant & Equip.$0$0$0$12K$7K
Goodwill & Intangibles$0$0$0$84K$84K
Long-Term Investments$0$0$1K$1K$1K
Other Non-Current Assets$0$0$19K-$96K-$9K
Total Non-Current Assets$0$0$20K$96K$83K
Total Assets$5K$973$126K$774K$219K
— Liabilities —
Accounts Payable$0$267K$46K$36K$104K
Short-Term Debt$792K$875K$46K$58K$670K
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$0$0$4K$5K$79K
Total Current Liabilities$1M$1M$99K$104K$869K
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$792K$883K$92K$0$0
Total Liabilities$1M$1M$99K$104K$869K
— Equity —
Common Stock$86K$86K$165K$301K$311K
Retained Earnings-$9M-$9M-$840K-$3M-$4M
Accumulated OCI-$5K$0-$1K-$999-$1K
Total Stockholders Equity-$1M-$1M$28K$670K-$650K
Total Liabilities & Equity$5K$973$126K$774K$219K
— Key Metrics —
Total Debt$792K$875K$46K$58K$670K
Net Debt$787K$874K-$7K-$441K$625K
Total Investments$0$0$1K$1K$1K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms